Volume 9, Issue 9 e1096
ORIGINAL ARTICLE
Open Access

Small noncoding RNA sRNA0426 is involved in regulating biofilm formation in Streptococcus mutans

Luoping Yin

Luoping Yin

Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-Sen University, Guangzhou, China

Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China

Contribution: Data curation (equal), ​Investigation (lead), Methodology (equal), Writing - original draft (equal), Writing - review & editing (equal)

Search for more papers by this author
Wenhui Zhu

Wenhui Zhu

Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-Sen University, Guangzhou, China

Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China

Contribution: Data curation (equal), ​Investigation (equal), Methodology (equal), Writing - original draft (equal), Writing - review & editing (equal)

Search for more papers by this author
Dongru Chen

Dongru Chen

Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-Sen University, Guangzhou, China

Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China

Contribution: Software (supporting), Writing - original draft (supporting)

Search for more papers by this author
Yan Zhou

Yan Zhou

Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-Sen University, Guangzhou, China

Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China

Contribution: ​Investigation (supporting), Methodology (supporting), Writing - review & editing (equal)

Search for more papers by this author
Huancai Lin

Corresponding Author

Huancai Lin

Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-Sen University, Guangzhou, China

Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China

Correspondence

Huancai Lin, Department of Preventive Dentistry, Guanghua School of Stomatology, Sun Yat-sen University, 56 Ling Yuan Road West, Guangzhou 510055, China.

Email: [email protected]

Contribution: Conceptualization (lead), Funding acquisition (equal), Writing - original draft (equal), Writing - review & editing (equal)

Search for more papers by this author

Luoping Yin and Wenhui Zhu contributed equally to this work.

Graphical Abstract

This study focuses on the role of small noncoding RNA both in standard Streptococcus mutans and clinical strain biofilms. sRNA0426 is potentially involved in the biofilm formation of S. mutans. The results of this study provide new insights into the complex biofilm regulatory network in S. mutans, which infers a new possibility for dental caries prevention.

Abstract

Evidence suggests that small noncoding RNAs (sRNAs) are involved in the complex regulatory networks governing biofilm formation. Few studies have investigated the role of sRNAs in Streptococcus mutans (S. mutans). In the present study, the association between sRNA and biofilm formation in S. mutans was explored. sRNAs that are differentially expressed in the biofilm and planktonic states of this bacterium were identified by quantitative real-time PCR (qRT-PCR). Confocal laser scanning microscopy was used to investigate the characteristics of biofilm formation in a standard strain of S. mutans (UA159, ATCC 700610) and ten clinical strains. Bioinformatics analyses were employed to predict and examine potential sRNA regulatory pathways. The results showed that sRNA0426 has a strong positive relationship with dynamic biofilm formation. Moreover, sRNA0426 expression was positively correlated with exopolysaccharide (EPS) production. Bioinformatics analyses showed that sRNA0426 is involved in biofilm formation such as metabolic pathways, especially carbon metabolism. Five target mRNAs (GtfB, GtfC, GtfD, ComE, and CcpA) involved in the synthesis of EPS were selected for further evaluation; the expression levels of three of these mRNAs (GtfB, GtfC, and CcpA) were positively correlated with sRNA0426 expression levels, and the expression level of one (ComE) was negatively correlated. In conclusion, the results suggested that sRNA0426 may play an important and positive role in the biofilm formation of S. mutans and provide novel insight into the S. mutans biofilm regulatory network.

1 INTRODUCTION

Streptococcus mutans (S. mutans), the bacterium currently recognized as the main microbiological cause of dental caries, depends on the formation of biofilms to exert its virulence (Klein, Hwang, Santos, Campanella, & Koo, 2015). Compared to the planktonic form, biofilm formation provides S. mutans with a better opportunity to adapt to the changing environment in the oral cavity over a planktonic condition (Flemming & Wingender, 2010; Krzysciak, Jurczak, Koscielniak, Bystrowska, & Skalniak, 2014; Welin-Neilands & Svensater, 2007). Therefore, it is important to explore the mechanism of biofilm formation in S. mutans.

Small noncoding RNAs (sRNAs) are typically 50–400 nt in length and continuously fine-tune regulatory networks to enable concentration-specific responses to environmental cues by sequestering, antagonizing, or activating regulatory mRNAs and proteins (Chambers & Sauer, 2013). sRNAs play pivotal roles in regulating gene expression under various conditions, thereby promoting adaptation to a changing environment, especially the biofilm microenvironment (Faizan et al., 2017; Roop et al., 2017; Tsai et al., 2013). It is increasingly appreciated that sRNAs are involved in the complex regulatory mechanisms that govern biofilm development, including the switch between planktonic and biofilm states in bacteria (Caldelari, Chao, Romby, & Vogel, 2013; Chambers & Sauer, 2013; Ghaz-Jahanian, Khodaparastan, Berenjian, & Jafarizadeh-Malmiri, 2013). For example, Zhao, Koestler, Waters, and Hammer (2013) found that Qrr sRNAs simultaneously negatively and positively regulate expression of the hapR gene and the vca0939 gene, respectively, to promote biofilm formation in Vibrio cholera. In Streptococcus sanguinis, two sRNAs that negatively regulate biofilm formation by inhibiting the expression of the target pilT gene were recently identified (Ota et al., 2018).

Additionally, Lee and Hong (2012) revealed more than 900 sRNAs and highlighted the importance of sRNAs in S. mutans. In a previous study, we established a library of 736 differentially expressed candidate sRNAs associated with initial adhesion in S. mutans UA159 by RNA deep sequencing (Zhu, Liu, Liu, Zhou, & Lin, 2018). Moreover, we observed a consistent correlation between the expression of sRNAs and initial adhesion ability in 100 clinical strains of S. mutans (Zhu et al., 2018). Initial adhesion is the first step in biofilm formation, the processes of which include reversible attachment, irreversible attachment, maturation, and dispersion (Hinsa, Espinosa-Urgel, Ramos, & O'Toole, 2003). The microbial composition and structure change dynamically during biofilm formation. Although sRNAs are widely considered to act as key regulators in biofilm formation (Svenningsen, 2018), there has been limited investigation of the role of these molecules in the dynamic process of biofilm formation (Kreth, Liu, Chen, & Merritt, 2015), and it remains unknown whether sRNA exerts an important role during the process of biofilm formation in S. mutans.

In this study, we first screened sRNAs associated with biofilm formation in the standard strain of S. mutans UA159 and then investigated the potential association between sRNAs and biofilm formation and the production of exopolysaccharide (EPS) in clinical strains of S. mutans. Bioinformatics analysis was used to predict and verify the potential regulatory mechanisms employed by candidate sRNAs. The results highlight the function of sRNAs in the dynamic regulation of biofilm formation and provide a promising avenue for developing novel methods of caries prevention by targeting S. mutans.

2 METHODS

2.1 Bacterial strain and culture conditions

The strains used in the present study included the standard strain of S. mutans (UA159ATCC 700610) and clinical isolates. Clinical isolates were obtained from an epidemiological survey conducted in Guangdong Province, People's Republic of China, in 2015 (Yu et al., 2015). The survey was conducted among 5-year-old children. A total of 215 clinical strains were isolated from 215 children with different caries status (Zhu et al., 2018). From these isolates, 10 clinical strains were randomly selected. The S. mutans strains were grown in brain heart infusion (BHI) broth (Oxoid) overnight under anaerobic conditions (80% N2, 20% CO2) at 37°C. The optical density at 600 nm (OD600) of overnight-cultured strains was measured using a microplate reader (Bio-tek, Epoch 2, America). UA159 suspensions (OD600 = 0.7) were inoculated at 1:20 into fresh BHI in round-bottom 6-well plates to obtain planktonic cells; the same suspensions (OD600 = 0.7) were inoculated at 1:20 into fresh BHI in flat-bottom 6-well plates and incubated for 4 h, 6 h, 12 h, and 24 h to monitor the dynamic biofilm formation process of S. mutans.

2.2 RNA extraction

Planktonic bacteria were collected by centrifugation at (13201 g) for 5 min. Biofilm bacteria were scraped from plates and centrifuged at (13201 g) for 5 min. Total RNA extraction was performed according to the method described by Zhu et al. (2017). Briefly, total RNA was stabilized with RNAprotect Bacteria Reagent (Qiagen) before extraction. Biofilms were harvested and washed three times with phosphate-buffered saline (PBS). The total RNA of biofilm cells was purified using a miRNeasy Mini Kit (Qiagen). A Thermo Scientific NanoDrop 2000 instrument (NanoDrop Technologies) and an Agilent 2100 system (Agilent Technologies) were used to assess RNA quality and quantity.

2.3 Quantitative real-time PCR (qRT-PCR)

The top twenty significantly differentially expressed sRNAs were selected as candidates from our sRNA library established in a previous study (Zhu et al., 2018). These candidate sRNAs were further analyzed between planktonic and biofilm conditions of S. mutans at 24 h by qRT-PCR. cDNA was synthesized using a Mir-X miRNA First-Strand Synthesis Kit (Takara and Clontech) according to the manufacturer's recommended protocol. qRT-PCR was performed using a LightCycler 96 Real-Time System and the SYBR Premix Ex Taq II Kit (Takara and Clontech). The primers used for sRNAs in this study are listed in Table 1. The reaction conditions were 95°C for 30 s followed by 40 cycles of 95°C for 15 s and 60–63°C for 30 s. The expressions of sRNAs were normalized to the 16S rRNA expression level.

TABLE 1. Primers for candidate sRNAs and 16S rRNA
sRNA ID Primers
Forward Reverse
sRNA0698 (Zhu et al., 2018) CTATTTCTGTTCTATTTTACCACA Universal primer
sRNA0593 (Zhu et al., 2018) CGCCAATCATTTCATTTTCCA CCTACGTTTCCCGTGCCTAA
sRNA0074 TACTGGAATAATGTTTAATTTTACT Universal primer
sRNA0522 CAATAGTAATAAGGTAAAGTGCG GTATCTCGTAAATACTACAAAGAATT
sRNA0426 ATTGGATAAGACCGTTACACA AAATAGCGAGACAAGAAAGTT
sRNA0413 AATAATAAGTCCGCAAAAATC AAGGTGGATTAGGTAAAGATG
sRNA0650 TTAGCATCTTTTACATCACAATA TGATTCTTCTTTATGGGACA
sRNA0146 AGCTAGTTGCTATAATTAATAATTT TTCTCTTCAGTTAGACAATCTCT
sRNA0215 TTGTGAAGCTCTCAATAAGTT GATGTATCCAATGAATCAGTGA
sRNA0120 TAAGCGTAAGCGGCAAAACT AATAGCTGGGCTTCAGGTGC
sRNA0118 AATATTGATTTTGACCTGCAT GATTTTAGGCTAACTTTTGAGAT
sRNA0379 AGTGCTTCTTCAATTTTATCCATC GGCAAGGATAGAATGGTTGT
sRNA0250 GCCATTTAAGATTCGGACTA AGGAAGTGAATAAGTATGAAAGT
sRNA0301 CTAAAGGGCAATAAAATATGTGA GAAGCGTTTCCTATAAATTCTAT
sRNA0600 TGTATTTGTTTCGGACCTTA CGCTATTACGCGATATTCT
sRNA0656 (Zhu et al., 2018) TATGGGGGATAAGATATGCTATGAT Universal primer
sRNA0330 (Zhu et al., 2018) TTTATTAGAAAGGAACAGTTTTG Universal primer
sRNA0187 (Zhu et al., 2018) CGTTCCGTCAAATAACCAAAGTG AAGGAGAATGGTAATTCCGCTTT
sRNA0329 (Zhu et al., 2018) GCAAAACTGTTCCTTTCTAATAA Universal primer
sRNA0679 (Zhu et al., 2018) AATCTCAAGCAAAGACTTTTTAGA Universal primer
16S rRNA CTTACCAGGTCTTGACATCCCG ACCCAACATCTCACGACACGAG
  • * The primers were designed by the technical staff from the TakaRa company. The universal primer was commercially supplied with the Mir-X miRNA qRT-PCR SYBR kits (TaKaRa).

The most highly expressed sRNA associated with biofilm formation from the analyzed 20 sRNAs was selected for further analysis. Five target mRNAs of the candidate sRNA were selected, and their possible functional roles were preliminarily explored. The primers used in the qRT-PCR analysis of the mRNAs are listed in Table 2. Synthesis of cDNA and qRT-PCR were performed as described above. The expression level of each gene was determined in triplicate. Expression levels were calculated using the 2−ΔΔCt method (Livak & Schmittgen, 2001).

TABLE 2. Primers for potential target mRNAs
Gene ID Primers
Forward Reverse
ComE (Hung et al., 2011) AGCCCATAAGCTCTGCCTTT AGCGATGGCACTGAAAAAGT
CcpA (Wen & Burne, 2002) ATTGACCGTCTTGATTATC AGCATTAGCAATATTAGGG
GtfB (Gao et al., 2018) AGCAATGCAGCCAATCTACAAAT ACGAACTTTGCCGTTATTGTCA
GtfC (Gao et al., 2018) CTCAACCAACCGCCACTGTT GGTTTAACGTCAAAATTAGCTGTATTAGC
GftD (Gao et al., 2018) ACAGCAGACAGCAGCCAAGA ACTGGGTTTGCTGCGTTTG

2.4 Crystal violet (CV) staining assay

The CV staining assay was used to evaluate the biofilm biomass of S. mutans (Weerasekera et al., 2016). Streptococcus mutans UA159 and the 10 clinical strains were incubated in flat-bottom 96-well plates under anaerobic conditions for 4 h, 6 h, 12 h, and 24 h. Then the contents of the 96-well plates were then removed, and the plates were washed three times with phosphate-buffered saline (PBS) to remove nonadherent cells. The washed biofilms were fixed with 95% methanol for 15 min and washed again. The biofilms were stained with 0.1% (wt/vol) CV solution for 15 min at room temperature. After thorough removal of the excess liquid, the remaining CV was dissolved in 200 μl of 95% ethanol for 15 min, and 100 μl of the sample was transferred to a new plate for OD600 measurement.

2.5 Confocal laser scanning microscopy (CLSM)

For analysis of EPS production, 1 μM Alexa Fluor 647 (Invitrogen) and 2.5 μM SYTO 9 (Invitrogen) were used to label dextran and bacterial cells, respectively (Huang et al., 2017). COMSTAT was used to analyze the biomass of EPS (μm3/μm2). The three-dimensional architecture of the biofilms was reconstructed using Imaris 8.0.2 (Bitplane). Three independent experiments were performed for each condition, and images of five random fields were collected for each sample.

2.6 Bioinformatics analysis of candidate sRNAs

We predicted the structures of candidate sRNA using RNAfold (http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi). According to sequence data for S. mutans UA159 (AE014133.2), functional annotation of sRNA was performed with the Kyoto Encyclopedia of Genes and Genomes analyses (KEGG) and Database for Annotation, Visualization and Integrated Discovery (DAVID) software (http://david.abcc.ncifcrf.gov/). The binding sites of sRNAs in putative target mRNAs were predicted by intaRNA (http://rna.informatik.uni-freiburg.de/IntaRNA/Input.jsp).

2.7 Statistical analyses

Each experiment was independently repeated three times. GraphPad Prism version 7.0a (GraphPad Software, San Diego, CA, USA) and IBM SPSS 24.0 (IBM, Armonk, NY, USA) were used to analyze the data. The means and standard deviations of all continuous variables were computed. The data were assessed for normal distribution and sphericity; an unpaired t test was used for two conditions, and repeated measures analysis of variance was used for multiple time points (p < 0.05). The Spearman rank correlation coefficient was applied with a p-value of <0.05 for correlation testing.

3 RESULTS

3.1 Screening for the most highly differentially expressed sRNAs associated with biofilm formation

To obtain the most relevant sRNAs associated with biofilm formation, we screened the top 20 differentially expressed sRNAs from our previous study in the standard strain of S. mutans (UA159, ATCC 700610). Among the 20 sRNAs, 18 were successfully detected with 14 were upregulated in cultures with biofilm status relative to those with planktonic status, and 4 were downregulated. Two sRNAs (sRNA0250 and sRNA0656) expressed so unstably after multiple repeated studies that the detection of these two sRNAs was not shown in Table 3. sRNA0426 was the most highly differentially expressed sRNA. Its expression was 5.87 times higher in the biofilm state than in the planktonic state (p < 0.001, Table 3).

TABLE 3. Analysis of the differential expression of 20 sRNAs between planktonic and biofilm conditions in standard Streptococcus mutans at 24 h
sRNAs log2 Fold change (Biofilm/Planktonic) Fold change (Biofilm/Planktonic) t value p-value
sRNA0426 2.55 5.87 26.09 <0.001
sRNA0379 2.33 5.01 54.82 <0.001
sRNA0650 2.19 4.56 54.31 <0.001
sRNA0413 2.13 4.38 71.42 <0.001
sRNA0600 1.99 3.97 19.11 <0.001
sRNA0522 1.79 3.46 55.26 <0.001
sRNA0698 1.29 2.45 20.36 <0.001
sRNA0593 1.27 2.42 9.86 <0.001
sRNA0215 1.14 2.20 13.78 <0.001
sRNA0120 0.84 1.79 7.52 <0.001
sRNA0146 0.81 1.75 8.99 <0.001
sRNA0118 0.69 1.62 19.42 <0.001
sRNA0301 0.54 1.45 17.93 <0.001
sRNA0074 0.17 1.13 2.74 0.021
sRNA0329 −0.66 0.63 −7.43 <0.001
sRNA0187 −1.18 0.44 −13.44 <0.001
sRNA0330 −1.23 0.43 −12.83 <0.001
sRNA0679 −1.25 0.42 −15.81 <0.001
sRNA0250 - - - -
sRNA0656 - - - -

Note

  • Expression of the 20 selected sRNAs under standard Streptococcus mutans biofilm conditions compared with planktonic conditions at 24 h. 18 sRNAs were differentially expressed between the two conditions; of these, sRNA0426 was the most significantly upregulated sRNA. The expression of sRNA0250 and sRNA0656 under these two conditions was not measured stably. The sequencing data for these sRNAs were obtained from (Zhu et al., 2018).

3.2 Expression of sRNA0426 during biofilm formation in standard and clinical strains of S. mutans

To further verify the relationship between sRNA0426 and biofilm formation, we first evaluated the biofilm biomass by CV assays and measured the expression of sRNA0426 at 4 h, 6 h, 12 h, and 24 h in the standard strain of S. mutans. The biofilm biomass increased from 4 h to 24 h during the biofilm formation process in the standard strain (p < 0.05, Figure 1a). Also, expression of sRNA0426 changed dynamically during biofilm formation in the standard strain, gradually increasing from 4 h to 12 h and then decreasing slightly at 24 h, with a peak at 12 h (p < 0.001) (Figure 1b). We observed a similar trend in the clinical strains of S. mutans (Figure 2a,b). There was a positive correlation between sRNA0426 expression and biofilm biomass in the clinical strains at various times (4 h, 6 h, 12 h, and 24 h). From 4 h to 12 h, the correlation strengthened as the biofilm formation capability of the 10 clinical strains increased, although the correlation weakened from 12 h to 24 h (Figure 2c-f). The strongest correlation between sRNA0426 expression and biofilm formation capability was observed at 12 h (r = 0.8252, p = 0.0033) (Figure 2e).

Details are in the caption following the image
Characteristics of biofilm formation and expression of sRNA0426 in the standard strain of Streptococcus mutans. (a) The biomass of biofilm (OD600) during biofilm formation by the standard strain was evaluated using the CV assay. (b) Dynamic expression analysis of sRNA0426 in the standard strain was performed. The level of expression of sRNAs at 4 h was defined as 1.0. Data represent the mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001
Details are in the caption following the image
Characteristics and association of biofilm formation with the expression of sRNA0426 in clinical strains of Streptococcus mutans. (a) Biofilm biomass (OD600) during biofilm formation by clinical strains of S. mutans. (b) Dynamic expression analysis of sRNA0426 in clinical strains of S. mutans. The level of expression of sRNAs at 4 h was defined as 1.0. (c-f) The level of expression of sRNA0426 in strain 5521 was defined as 1.0. Spearman correlation analysis of sRNA0426 expression with biofilm formation is shown in the figure for the 10 clinical isolates at 4 h, 6 h, 12 h, and 24 h. Data represent the mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001

3.3 Relationship between expression of sRNA0426 and EPS

EPS forms the core of the matrix scaffold and provides binding sites that promote the accumulation of microorganisms on the tooth surface and the establishment of pathogenic biofilms (Bowen, Burne, Wu, & Koo, 2018). Thus, to further explore the association between sRNA0426 and EPS, we specifically analyzed EPS by CLSM. According to the confocal micrographs of EPS, the bacteria became increasingly encased or surrounded by EPS with time, but no change was apparent from 12 h to 24 h (Figure 3a,b). The highest biovolume of EPS was observed at 12 h in the biofilm of both the standard and clinical strains of S. mutans (p < 0.05) (Figure 3c,d), and the trend of the change in the amount of EPS was consistent with the dynamic expression of sRNA0426 during biofilm formation. We then analyzed the relationship between expression of sRNA0426 and the amount of EPS in the biofilms of the 10 clinical strains at 4 h, 6 h, 12 h, and 24 h of culture. The results obtained with the clinical strains suggest that the expression level of sRNA0426 correlates positively with the amount of EPS present during biofilm formation. The strongest correlation was observed at 12 h (r = 0.8663, p = 0.0012) (Figure 4c). These results indicate that sRNA0426 may play a positive role in the production of EPS in S. mutans biofilms.

Details are in the caption following the image
EPS analysis of Streptococcus mutans. (a-b) Three-dimensional reconstructions of live bacteria and EPS in biofilms of standard S. mutans and one representative clinical strain at 4 h, 6 h, 12 h, and 24 h. EPS is labeled in red (Alexa Fluor 647), and bacterial cells are labeled in green (SYTO9). (c-d) EPS biomasses of standard S. mutans and 10 S. mutans clinical strains at 4 h, 6 h, 12 h, and 24 h. EPS biomasses were calculated according to 5 random sites in each CLSM micrograph image. Each determination was repeated three times
Details are in the caption following the image
Correlation of sRNA0426 expression with EPS. (a-d) The level of expression of sRNA0426 in strain 5521 was defined as 1.0. Spearman correlation analysis of sRNA0426 relative expression with EPS is shown in the figure for the 10 clinical isolates at 4 h, 6 h, 12 h, and 24 h. *p < 0.05, **p < 0.01, ***p < 0.001

3.4 Functional annotation of sRNA0426 using bioinformatics analyses

Considering the importance of secondary structures in stabilizing sRNAs, the secondary structure of sRNA0426 was predicted using RNAfold. It is reported that sRNA0426 possesses a stem-loop structure with a ΔG value of −18.7 kcal/mol (Figure 5a). To the best of our knowledge, sRNA0426 is located on the antisense mRNA strand between SMU_1238c and SMU_1239 (Table A1). To explore the potential mechanism by which sRNA0426 regulates S. mutans biofilm formation, KEGG pathway annotation was used to investigate the sRNA0426 regulatory pathway, revealing eight pathways that are significantly regulated by sRNA0426 (p < 0.05) (Figure 5b). Specifically, most of the pathways are involved in biofilm formation, such as metabolic pathways, especially carbon metabolism. The results of the KEGG analysis of biological pathways for the other sRNAs are presented in Appendix B (https://doi.org/10.6084/m9.figshare.12310133). The KEGG analysis for the other differential sRNAs expression showed a potential similar pathway with sRNA0426 and that there might be several sRNAs involved in the biofilm regulatory network in S. mutans.

Details are in the caption following the image
Bioinformatics analyses of sRNA0426. (a) The secondary structure of sRNA0426 predicted by RNAfold. Different colors indicate the probabilities of base composition in the secondary structure as graphic symbols. sRNA0426 possesses a stem-loop structure with a dG value of −18.7 kcal/mol. (b) Biological pathways predicted by KEGG analysis for target mRNAs of sRNA0426 at p < 0.05

To determine whether similar putative sRNAs are present in other bacteria, we searched for sequences homologous of sRNA0426 using BLASTN. The results are shown in Figure 6. A sequence was only considered to be conserved when the coverage between the query and subject sequences was higher than 75% and the nucleotide identity was higher than 65% (E-value = 10−5, word = 11). The results suggest that sRNA0426 might be conserved in Streptococcus species, primarily in S. mutans strains and Streptococcus troglodytae (S. troglodytae). The genomes of 14 S. mutans strains were found to cover 100% of the sequence of sRNA0426. The S. mutans strain LAB761 and S. troglodytae separately cover 98.45% and 95.35% of the sequence respectively (Figure 6a). Furthermore, 14 streptococcus species including 105 strains have a 24%–27% query cover of sRNA0426. The BLASTN results of the representative 14 streptococcus species were shown in Figure 6b, and more details about the total 105 strains were presented in Appendix C (https://doi.org/10.6084/m9.figshare.12310133). We consider it specific seed sequences for the function of sRNA0426 in S. mutants.

Details are in the caption following the image
(a) Sequence alignment of putative homologs of confirmed sRNA0426 in Streptococcus mutans. (b) Sequence analysis of the seed sequence of sRNA0426. Only the representative 14 strains of these species were listed in the figure

3.5 Relationship of sRNA0426 and potential target mRNAs

To further explore the function of sRNA0426, we examined the association between sRNA0426 and five potential target mRNAs predicted by bioinformatics (GtfB, GtfC, GtfD, ComE, and CcpA) at 12 h, when the strongest correlation was observed between sRNA0426 and biofilm biomass together with EPS. According to the results, sRNA0426 expression showed a significantly positive relationship with GtfB, GtfC, ComE, and CcpA expression (p < 0.05) but no significant relationship with GtfD expression (Figure 7). Potential binding sites were also predicted by intaRNA (Figure A1). The presence of binding sites between potential target mRNAs and sRNA0426 provides evidence for a regulatory role of sRNA0426.

Details are in the caption following the image
The potential role of sRNA0426 in biofilm formation. (a-e) The level of expression of sRNA0426 and potential target mRNAs in strain 5521 was defined as 1.0. Spearman correlation analysis of sRNA0426 expression with ComE, GtfBCD, and CcpA is shown in the figure for the 10 clinical isolates at 12 h

4 DISCUSSION

Biofilm formation of S. mutans is a dynamic process that involves biofilm-specific genetic mechanisms and regulatory networks that allow the bacterium to adapt to a changing microenvironment (Krzysciak et al., 2014). sRNAs are reported to exert broad regulation by directly targeting a large number of mRNAs, thereby playing a crucial role in biofilm formation (Caldelari et al., 2013; Chambers & Sauer, 2013). However, identification and further analysis of biofilm-associated sRNAs in S. mutans have yet to be performed, especially in clinical strains. In this study, we detected the expression of sRNAs associated with biofilm formation and preliminarily investigated the potential function of sRNAs during biofilm formation both in standard S. mutans strain and clinical strains. Genes that are differentially expressed between biofilm and planktonic states are considered to be highly associated with biofilm formation. In Acinetobacter baumannii, Alvarez-Fraga et al. (2017) found that sRNA13573 was expressed more highly in biofilms than during planktonic states and verified that sRNA13573 was involved in biofilm formation. A previous study also showed that biofilm-associated genes exhibit different expression profiles in S. mutans under biofilm and planktonic conditions (Shemesh, Tam, & Steinberg, 2007). In our study, the expression of sRNA0426 was significantly higher in biofilms than in the planktonic state, and it changed dramatically during the biofilm formation process, showing a strong association with biofilm formation. Together with the correlation between sRNA0426 and biofilm biomass, the data suggest that sRNA0426 is associated with biofilm formation in S. mutans.

Biofilms are highly dynamic and structured communities of bacteria enmeshed in a self-produced matrix of extracellular polymeric substances (Flemming & Wingender, 2010; Flemming et al., 2016). EPS forms the core of the matrix scaffold and provides a binding site for bacterial cells, mediating their adherence to form mature biofilms (Koo, Falsetta, & Klein, 2013). As attractive and effective regulators, sRNAs have an important function in the production of EPS. Liu reported that the sRNA HmsB (sR035) promotes biofilm formation by increasing EPS production and that HmsA (sR084) activates biofilm formation by modulating the intracellular level of c-di-GMP molecules to determine EPS production in Yersinia pestis (Liu et al., 2016). Additionally, sRNAs cooperate with Hfq to regulate EPS production in Erwinia amylovora (Zeng, McNally, & Sundin, 2013). In the present study of S. mutans, sRNA0426 displayed a positive correlation with EPS. The results suggest that sRNA0426 plays an important role in S. mutans biofilm formation through the production of EPS.

Synthesis of EPS is determined by carbon metabolism, which in S. mutans is mainly controlled by glucosyltransferases (gtfs). GtfBC metabolizes sucrose to produce water-insoluble glucans, and gtfD synthesizes predominantly soluble glucans to establish the EPS matrix (Li & Burne, 2001). The activities of gtfs are controlled by regulators. For example, comE is part of two-component signal transduction systems and it is an occluded RNA polymerase that binds to the coding region of gtfC to abort its expression, thereby interfering with carbon metabolism and biofilm formation (Hung et al., 2011). Furthermore, ccpA plays a critical role in the response to carbon source availability by affecting the stability of biofilms in S. mutans, and the gtfBC genes require ccpA for optimal expression (Wen & Burne, 2002).

In general, sRNAs regulate gene expression by base-pairing with target mRNAs or by binding proteins directly (Chambers & Sauer, 2013) Associations between sRNA0426 and target mRNAs, including GtfB, GtfC, ComE, and CcpA, were examined, and the results further supported the role of sRNA0426 in the production of EPS biomass. The positive correlation between GtfB, GtfC, CcpA, and sRNA0426 expression, together with the negative correlation between ComE and sRNA0426, suggest that sRNA0426 might be positively associated with biofilm formation in the regulation of EPS. KEGG analysis of the predicted target genes of sRNA0426 suggests that sRNA0426 is involved in diverse physiological activities through 8 pathways (p < 0.05), such as metabolic pathways including carbon metabolism and microbial metabolism in diverse environments, that are associated with biofilm formation. What's more, the seed sequence is necessary but insufficient (Didiano & Hobert, 2006; Lee et al., 2016). And the most stable predicted binding sites between the biofilm-associated mRNAs and sRNA0426 are not limited in the seed sequence. Therefore, the seed sequence of sRNA0426 might serve an important role for sRNA0426, but the association between it and the function of sRNA0426 in S. mutants on biofilm formation is needed to be further verified (Fritsch, Siqueira, & Schrank, 2018). Overall, the functions of sRNAs may be more complex than once considered. The present study is a primary exploration of biofilm-associated sRNAs in S. mutans. The identification of more potential sRNAs and function analysis of additional sRNAs are required, and especially creating mutans to further analyze the role of sRNAs in S. mutans is needed. We have tried and failed to create mutant strains. The details are described in the Appendix A and shown in Figure A2. This could point to an essential function of this sRNA or more attempts to try.

In conclusion, we first explored the expression characteristics and potential functions of sRNAs in the biofilm formation process of standard S. mutans and clinical strains. We found that sRNA0426 and its target mRNAs are dynamically involved in the synthesis of EPS and biofilm-associated pathways. The results presented herein suggest the presence of a novel regulator in S. mutans under biofilm conditions, providing a better understanding of the mechanism of biofilm formation.

ACKNOWLEDGMENTS

This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81570967).

    CONFLICT OF INTEREST

    None declared.

    AUTHOR CONTRIBUTIONS

    Luoping Yin: Data curation (equal); investigation (lead); methodology (equal); writing – original draft (equal); writing – review & editing (equal). Wenhui Zhu: Data curation (equal); investigation (equal); methodology (equal); writing – original draft (equal); writing – review & editing (equal). Dongru Chen: Software (supporting); writing – original draft (supporting). Yan Zhou: Investigation (supporting); methodology (supporting); writing – review & editing (equal). Huancai Lin: Conceptualization (lead); funding acquisition (equal); Writing – original draft (equal); writing – review & editing (equal).

    ETHICS STATEMENT

    The study protocol was approved by the Ethics Committee of the Guanghua School of Stomatology, Sun Yat-sen University (ERC-[2015]-09). The parents of all of the participants consented to the research.

    Appendix A

    Construction of the sRNA0426 deletion

    Considering the length of sRNA0426 and the situation that there was no referable study of sRNAs deletion in Streptococcus mutans, we decided to attempt to construct the sRNA0426 deletion by markerless mutagenesis (Geng et al., 2016; McDaniel, Mackay, Quiroz, & Chilkoti, 2010). The knockout cassette for double-crossover homologous recombination was amplified from p15A (Selzer, Som, Itoh, & Tomizawa, 1983), named pTG17301. pTG17301 contains a counter selectable marker (phes) (Liu et al., 2020) and antibiotics marker that works in both Gram-negative and Gram-positive bacteria and will not lead to polar effects. Then, primers sRNA0426 LF and sRNA0426 RF were used to amplify the left and right flanks of sRNA0426 from the regions adjacent to its coding region of S. mutans UA159, generating 971-bp and 992-bp amplicons. The left flank region and the right flank region were ligated to pTG17301 by seamless ligation (Tolobio Ezmax one-step cloning Kit), creating plasmid pTC17316. And the left flank region and the right flank region were also ligated together by seamless ligation to replace the knockout cassette. The gene replacement vector was transformed into S. mutans UA159 in the presence of 1 μg/μl competence-stimulating peptide. Following the allelic exchange, S. mutans UA159 with sRNA0426 deficiency was isolated on BHI and chemically defined medium (CDM) (van de Rijn & Kessler, 1980) agar plates, with or without exogenous d-Glu (30 mM), supplemented with 100 μg/ml antibiotics and further confirmed using colony Polymerase chain reaction (PCR) and agarose gel electrophoresis (AGE).

    Construction failure of the sRNA0426 deletion

    We carried many attempts to construct mutant strains, such as circular plasmid and linear plasmid transformation by chemical transformation and electrotransformation under different conditions. All the results were negative. In the control plates of S. mutans UA159, no strain was grown (Figure A2a). In the vast majority transformation plates, almost no possible deletion strain was grown (Figure A2b). And in the very few transformation plates strain, a small number of possible deletion strains were grown (Figure A2c). In confirmation of AGE, the lane of the wild type was located at 2000 bp, while the positive colony should be located at 4000 bp. Although there are some potential positive colonies in the transformation plates, the results suggested that only the bands of 2000 bp were detected, which meant the verified strains were all false positive (Figure A2d).

    Discussion

    We have tried and failed to construct a sRNA0426 mutant strain for S. mutans. This could point to an essential function of sRNA0426 or more attempts to improve the experimental methods and more trials. The present results might suggest a possibility of an important role of sRNA0426, and another situation is that homologous recombination is a probabilistic event where the times of repetitions were not enough under the tough condition of the length of sRNA0426 together with its stability. We might make a further try and confirmation of the role of sRNA0426 in the future.

    Details are in the caption following the image
    Putative binding sites for sRNA0426 in GtfBC, ComE, and CcpA as predicted by intaRNA. The bases of sRNA0426 are shown on the bottom
    Details are in the caption following the image
    (a) Transformation plates of control culture plate of Streptococcus mutans UA159 with the addition of antibiotics for the sRNA0426 deletion attempt in S. mutans. (b) One of the representative transformation plates in which possible deletion strains were almost not grown. (c) One of the transformation plates in which few possible deletion strains were grown. (d) Representative gel electrophoresis results of the grown colony PCR. Lane M showed the DNA Ladder. The AGE lane of wild type (UA159) was shown as negative control, and the AGE lane of pT17316 was shown as a positive control. The lane of the wild type was located at 2000 bp, while the positive colony should be located at 4000 bp
    TABLE A1. The location information for 20 sRNAs
    sRNA ID Length Begin End Strand Pre-gene Next-gene Direction Description Sequence
    >sRNA0698 49 1,975,630 1,975,678 + SMU_2102 SMU_2104 /−/+/+/ IGR TATATTCTTTACTTCTATTTCTGTTCTATTTTACCACAAAAACAACAGA
    >sRNA0593 103 1,744,776 1,744,878 + SMU_1846c SMU_1847 /−/+/−/ AM TAACAATTTCGCCAATCATTTCATTTTCCATCAAACTTGTCCTTTCTAATAAATTCATCCAAAACTGTTTTCCTTAGGCACGGGAAACGTAGGTTCCCTCAGC
    >sRNA0074 32 155,985 156,016 SMU_153 SMU_154 /+/−/+/ IGR AAACGGCTACTGGAATAATGTTTAATTTTACT
    >sRNA0522 132 1,501,217 1,501,348 SMU_1573 SMU_1574c /−/−/−/ IGR ATTTTCCCTTCTTAAGTTTCTTTTAAGAATCCTATCTTATACTATAGTCATCCTAGCAATAGGAATCCTAAAACTTTTCTTTTTCATAAATCTCCTAAGAATCTCAGTCCATTCGGACTGGGATTTTTTTGC
    >sRNA0426 129 1,177,303 1,177,431 + SMU_1238c SMU_1239 /−/+/−/ AM TAATTTCTTCAAGACTTGTCATAATAACCTCTTTCTCGTTATTAATTGGATAAGACCGTTACACAAATAATATTCGTTGAACTTTCTTGTCTCGCTATTTGATCAATTCATAAATGGCTTCTGCATAAA
    >sRNA0413 118 1,140,596 1,140,713 + SMU_1197 SMU_t37 /+/+/−/ AM ATATTAACTAATAATAAGTCCGCAAAAATCGGGTATCAAAACTACTTTTTGTAAAAGCACCGCTTTCATCTTTACCTAATCCACCTTGAGGGAATCGAACCCCCATCTCAAGAACCGG
    >sRNA0650 119 1,848,993 1,849,111 + SMU_1975c SMU_1976c /−/+/−/ AM TAATTAGCATCTTTTACATCACAATAAGTGATTGAAGAACACTCTAAGTAAAACGCCACATATGATTGTCCCATAAAGAAGAATCATCAGAGTAATCAGATAGCTGAAAGCGATATGCC
    >sRNA0146 95 359,440 359,534 + SMU_379 SMU_381c /+/+/−/ IGR AGAGCTAGTTGCTATAATTAATAATTTACTAGAGATTGTCTAACTGAAGAGAAGTAGTGTCTAATAGATGTTCATTATTAGCGCACGGCCATTAC
    >sRNA0215 147 556,,934 557,080 SMU_597 SMU_598 /+/−/+/ AM AAGCTAAGCGAGTCGCTGTTTTGATACCAATACCCGGTAATTTTGTGAAGCTCTCAATAAGTTTGGCAATAGGCGTTGGGTAGAGCATTCTTTTTCCTCACTGATTCATTGGATACATCTTTTGATAAAGATTGATGATATCTCTCG
    >sRNA0120 111 287,424 287,534 + SMU_298 SMU_299c /+/+/−/ AM TAACAATATGAACGATTATCTTAATGACTTAAGCGTAAGCGGCAAAACTTGCTGCACCTGAAGCCCAGCTATTTACTACAACGTCTGTTAAAGCTTGTGCTGGAGTTTTTG
    >sRNA0118 100 279,927 280,026 + SMU_291 SMU_292 /+/+/+/ IGR TAATGTTAAAAGCTTTTAAAAACAGCTTCTTAGAAATATTGATTTTGACCTGCATCTCAAAAGTTAGCCTAAAATCTAACTTTTGGGGTGTTTTTCTATG
    >sRNA0379 58 1,028,561 1,028,618 + SMU_1083c SMU_1084 /−/+/−/ AM TAAGTGCTTCTTCAATTTTATCCATCGTCAACCACAACCATTCTATCCTTGCCAAAAC
    >sRNA0250 88 621,927 622,014 SMU_662 SMU_663 /+/−/+/ AM TCTGATGGCCATTTAAGATTCGGACTAATTCTAATCCACTATATCCTGTAATACCGACAATCGAAACTTTCATACTTATTCACTTCCT
    >sRNA0301 87 745,713 745,799 SMU_799c SMU_800 /−/−/+/ IGR CTAAAGGGCAATAAAATATGTGATTCCAAAGCTTCAACAGTAACCTTTAATGGGAATATAGAATTTATAGGAAACGCTTCCAAAATT
    >sRNA0600 139 1,757,677 1,757,815 + SMU_1862 SMU_1865 /+/+/+/ IGR TAGCTTTTCAACTTTAGCAAGAATCAGTACAACAACTCCTAGCAAAGCTGTTCGCTGTATTTGTTTCGGACCTTAGTCTCTTAGAATATCGCGTAATAGCGATTTATGCCATTTTTTACTTTAAAATCAAATAGTTGGT
    >sRNA0656 113 1,849,900 1,850,012 SMU_1977c SMU_1978 /−/−/−/ IGR GTAAAAGAGATTTGACATCTCTCACTAAATAGTAATTATGGGGGATAAGATATGCTATGATCATTAAAAAGATATTTAGTCAAGAATATTTCAGTACAACTTTAGTCAAATAG
    >sRNA0330 25 827,355 827,379 SMU_875c SMU_876 /−/−/−/ IGR TTTATTAGAAAGGAACAGTTTTGCA
    >sRNA0187 118 460,,778 460,895 SMU_491 SMU_493 /+/−/+/ AM TATCACGATAACTGTACATGCGTTCCGTCAAATAACCAAAGTGTTTTTGAGAATTCTTTTGAACATCATTTGTGTACTTTTGAGTTAAAAGCGGAATTACCATTCTCCTTCTCCTTTT
    >sRNA0329 38 827,341 827,378 + SMU_875c SMU_876 /−/+/−/ IGR GTATCGCAAACGTTTGCAAAACTGTTCCTTTCTAATAA
    >sRNA0679 53 1,922,203 1,922,255 + SMU_2046c SMU_2047 /−/+/−/ AM AATCTCAAGCAAAGACTTTTTAGATTCTAGCCTACTCCTTTTTAATCTTTTTA

    Note

    • The data are extracted from Zhu et al. (2018). AM indicates that the sRNA is located on the antisense strand to mRNA; IGR indicates that the sRNA is in the intergenic region.

    Appendix B

    KEGG_PATHWAY analysis for sRNA0379
    Term Genes % p -value
    Metabolic pathways image 17.3 0.000
    Biosynthesis of secondary metabolites image 8.2 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.010
    Purine metabolism image 2.4 0.022
    Pyrimidine metabolism image 2.1 0.047

    KEGG_PATHWAY analysis for sRNA0650
    Term Genes % p -value
    Metabolic pathways image 17.2 0.000
    Biosynthesis of secondary metabolites image 8.1 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.011
    Purine metabolism image 2.4 0.024
    Pyrimidine metabolism image 2 0.049

    KEGG_PATHWAY analysis for sRNA0413
    Term Genes % p -value
    Metabolic pathways image 17.2 0.000
    Biosynthesis of secondary metabolites image 8.1 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.012
    Purine metabolism image 2.4 0.025

    KEGG_PATHWAY analysis for sRNA0600
    Term Genes % p -value
    Metabolic pathways image 17.2 0.000
    Biosynthesis of secondary metabolites image 8.1 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.012
    Purine metabolism image 2.4 0.025

    KEGG_PATHWAY analysis for sRNA0522
    Term Genes % p -value
    Metabolic pathways image 17.2 0.000
    Biosynthesis of secondary metabolites image 8.1 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.011
    Purine metabolism image 2.4 0.024
    Pyrimidine metabolism image 2 0.049

    KEGG_PATHWAY analysis for sRNA0698
    Term Genes % p -value
    Metabolic pathways image 17.4 0.000
    Biosynthesis of secondary metabolites image 8.2 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.8 0.001
    Carbon metabolism image 2.8 0.009
    Purine metabolism image 2.4 0.020
    Pyrimidine metabolism image 2.1 0.042

    KEGG_PATHWAY analysis for sRNA0593
    Term Genes % p -value
    Metabolic pathways image 17.2 0.000
    Biosynthesis of secondary metabolites image 8.1 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.012
    Purine metabolism image 2.4 0.025

    KEGG_PATHWAY analysis for sRNA0215
    Term Genes % p -value
    Metabolic pathways image 17.2 0.000
    Biosynthesis of secondary metabolites image 8.1 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.012
    Purine metabolism image 2.4 0.025

    KEGG_PATHWAY analysis for sRNA0120
    RT Genes % p -value
    Metabolic pathways image 17.2 0.000
    Biosynthesis of secondary metabolites image 8.1 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.012
    Purine metabolism image 2.4 0.025

    KEGG_PATHWAY analysis for sRNA0146
    Term Genes % p -value
    Metabolic pathways image 17.3 0.000
    Biosynthesis of secondary metabolites image 8.1 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.011
    Purine metabolism image 2.4 0.024
    Pyrimidine metabolism image 2 0.049

    KEGG_PATHWAY analysis for sRNA0118
    Term Genes % p -value
    Metabolic pathways image 17.2 0.000
    Biosynthesis of secondary metabolites image 8.1 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.012
    Purine metabolism image 2.4 0.025

    KEGG_PATHWAY analysis for sRNA0301
    Term Genes % p -value
    Metabolic pathways image 17.2 0.000
    Biosynthesis of secondary metabolites image 8.1 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.012
    Purine metabolism image 2.4 0.025

    KEGG_PATHWAY analysis for sRNA0074
    Term Genes % p -value
    Metabolic pathways image 17.2 0.000
    Biosynthesis of secondary metabolites image 8.1 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.012
    Purine metabolism image 2.4 0.025

    KEGG_PATHWAY analysis for sRNA0329
    Term Genes % p -value
    Metabolic pathways image 17.4 0.000
    Biosynthesis of secondary metabolites image 8.2 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.8 0.001
    Carbon metabolism image 2.8 0.010
    Purine metabolism image 2.4 0.022
    Pyrimidine metabolism image 2.1 0.047

    KEGG_PATHWAY analysis for sRNA0187
    Term Genes % p -value
    Metabolic pathways image 17.2 0.000
    Biosynthesis of secondary metabolites image 8.1 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.012
    Purine metabolism image 2.4 0.025

    KEGG_PATHWAY analysis for sRNA0330
    Term Genes % p -value
    Metabolic pathways image 17.3 0.000
    Biosynthesis of secondary metabolites image 8.2 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.012
    Purine metabolism image 2.4 0.025

    KEGG_PATHWAY analysis for sRNA0679
    Term Genes % p -value
    Metabolic pathways image 17.2 0.000
    Biosynthesis of secondary metabolites image 8.1 0.000
    Biosynthesis of antibiotics image 6 0.000
    Biosynthesis of amino acids image 5.2 0.000
    Microbial metabolism in diverse environments image 4.2 0.000
    ABC transporters image 3.7 0.001
    Carbon metabolism image 2.8 0.010
    Purine metabolism image 2.4 0.022
    Pyrimidine metabolism image 2 0.047

    Appendix C

    Sequences producing significant alignments:

    Description Max score Total score Alignment length Query cover Mismatch E-value Per.Ident Accession
    Streptococcus mutans strain P1 233 233 129 100% 0 0.000 100 CP050273.1
    Streptococcus mutans strain P6 233 233 129 100% 0 0.000 100 CP050272.1
    Streptococcus mutans strain S1 233 233 129 100% 0 0.000 100 CP050271.1
    Streptococcus mutans strain S4 233 233 129 100% 0 0.000 100 CP050270.1
    Streptococcus mutans strain NCH105 233 233 129 100% 0 0.000 100 CP044221.1
    Streptococcus mutans strain UA140 233 233 129 100% 0 0.000 100 CP044495.1
    Streptococcus mutans strain T8 233 233 129 100% 0 0.000 100 CP044492.1
    Streptococcus mutans strain MD 233 233 129 100% 0 0.000 100 CP044493.1
    Streptococcus mutans NBRC 13955 233 233 129 100% 0 0.000 100 AP019720.1
    Streptococcus mutans strain NCTC10832 233 233 129 100% 0 0.000 100 LR134320.1
    Streptococcus mutans strain NCTC10449 233 233 129 100% 0 0.000 100 LS483349.1
    Streptococcus mutans strain LAR01 233 233 129 100% 0 0.000 100 CP023477.1
    Streptococcus mutans strain KCOM 1054 (= ChDC YM3) 233 233 129 100% 0 0.000 100 CP021318.1
    Streptococcus mutans strain NG8 233 233 129 100% 0 0.000 100 CP013237.1
    Streptococcus mutans UA159-FR 233 233 129 100% 0 0.000 100 CP007016.1
    Streptococcus mutans GS-5 233 233 129 100% 0 0.000 100 CP003686.1
    Streptococcus mutans LJ23 233 233 129 100% 0 0.000 100 AP012336.1
    Streptococcus mutans UA159 233 233 129 100% 0 0.000 100 AE014133.2
    Streptococcus mutans NN2025 233 233 129 100% 0 0.000 100 AP010655.1
    Streptococcus mutans strain LAB761 224 224 129 100% 2 0.000 98.45 CP033199.1
    Streptococcus troglodytae TKU31 DNA 206 206 129 100% 6 0.000 95.35 AP014612.1
    Streptococcus oralis subsp. dentisani strain F0392 58.1 58.1 34 26% 1 0.000 97.06 CP034442.1
    Streptococcus oralis Uo5 58.1 58.1 34 26% 1 0.000 97.06 FR720602.1
    Streptococcus suis strain WUSS351 55.4 55.4 35 27% 2 0.001 94.29 CP039462.1
    Streptococcus sp. 1643 54.5 54.5 32 25% 1 0.002 96.88 CP040231.1
    Streptococcus sp. oral taxon 064 strain W10853 54.5 54.5 32 25% 1 0.002 96.88 CP016207.1
    Streptococcus milleri strain NCTC10708 53.6 53.6 34 26% 2 0.002 94.12 LR134307.1
    Streptococcus suis strain HA1003 53.6 53.6 34 26% 2 0.002 94.12 CP030125.1
    Streptococcus suis strain 1081 53.6 53.6 34 26% 2 0.002 94.12 CP017667.1
    Streptococcus suis strain 0061 53.6 53.6 34 26% 2 0.002 94.12 CP017666.1
    Streptococcus pantholopis strain TA 26 53.6 53.6 34 26% 2 0.002 94.12 CP014699.1
    Streptococcus constellatus subsp. pharyngis C1050 53.6 53.6 34 26% 2 0.002 94.12 CP003859.1
    Streptococcus constellatus subsp. pharyngis C818 53.6 53.6 34 26% 2 0.002 94.12 CP003840.1
    Streptococcus constellatus subsp. pharyngis C232 53.6 53.6 34 26% 2 0.002 94.12 CP003800.1
    Streptococcus suis isolate GD-0088 50.9 50.9 35 27% 3 0.023 91.43 LR738723.1
    Streptococcus suis isolate 861160 50.9 50.9 35 27% 3 0.023 91.43 LR738722.1
    Streptococcus suis isolate GD-0001 50.9 50.9 35 27% 3 0.023 91.43 LR738720.1
    Streptococcus suis strain AH681 50.9 50.9 35 27% 3 0.023 91.43 CP025043.1
    Streptococcus sp. 116-D4 50 50 32 25% 2 0.023 93.75 AP021887.1
    Streptococcus mitis strain SK637 50 50 32 25% 2 0.023 93.75 CP028415.1
    Streptococcus pneumoniae strain 2245STDY6179186 50 50 32 25% 2 0.023 93.75 LR216066.1
    Streptococcus oralis strain NCTC11427 50 50 32 25% 2 0.023 93.75 LR134336.1
    Streptococcus oralis strain FDAARGOS_367 50 50 32 25% 2 0.023 93.75 CP023507.1
    Streptococcus oralis strain S.MIT/ORALIS-351 50 50 32 25% 2 0.023 93.75 CP019562.1
    Streptococcus mitis strain SVGS_061 50 50 32 25% 2 0.023 93.75 CP014326.1
    Streptococcus sp. VT 162 50 50 32 25% 2 0.023 93.75 CP007628.2
    Streptococcus pseudopneumoniae IS7493 50 50 32 25% 2 0.023 93.75 CP002925.1
    Streptococcus pneumoniae strain PZ900701590 49.1 49.1 34 26% 3 0.079 91.18 CP050175.1
    Streptococcus thermophilus strain ATCC 19258 49.1 49.1 34 26% 3 0.079 91.18 CP038020.1
    Streptococcus equi subsp. zooepidemicus strain TN-714097 49.1 49.1 34 26% 3 0.079 91.18 CP046042.2
    Streptococcus equi subsp. zooepidemicus strain OH-71905 49.1 49.1 34 26% 3 0.079 91.18 CP046040.1
    Streptococcus pneumoniae strain R6CIB17 49.1 49.1 34 26% 3 0.079 91.18 CP038808.1
    Streptococcus pneumoniae strain 4559 49.1 49.1 34 26% 3 0.079 91.18 LR595848.1
    Streptococcus equi subsp. zooepidemicus strain NCTC11854 49.1 49.1 34 26% 3 0.079 91.18 LR590471.1
    Streptococcus pneumoniae isolate GPS_ZA_821-sc-1950967 49.1 49.1 34 26% 3 0.079 91.18 LR536845.1
    Streptococcus pneumoniae strain 2245STDY6178854 49.1 49.1 34 26% 3 0.079 91.18 LR536841.1
    Streptococcus pneumoniae strain 2245STDY6105855 49.1 49.1 34 26% 3 0.079 91.18 LR536839.1
    Streptococcus pneumoniae strain 2245STDY6106635 49.1 49.1 34 26% 3 0.079 91.18 LR536837.1
    Streptococcus pneumoniae strain 2245STDY6020240 49.1 49.1 34 26% 3 0.079 91.18 LR536835.1
    Streptococcus pneumoniae strain 2245STDY5775553 49.1 49.1 34 26% 3 0.079 91.18 LR536833.1
    Streptococcus pneumoniae strain 2245STDY5699475 49.1 49.1 34 26% 3 0.079 91.18 LR536831.1
    Streptococcus pneumoniae strain 521 49.1 49.1 34 26% 3 0.079 91.18 CP036529.1
    Streptococcus pneumoniae strain EF3030 49.1 49.1 34 26% 3 0.079 91.18 CP035897.1
    Streptococcus pneumoniae strain 2245STDY6178828 49.1 49.1 34 26% 3 0.079 91.18 LR216069.1
    Streptococcus pneumoniae isolate b04a6400-1f66-11e7-b93e-3c4a9275d6c8 49.1 49.1 34 26% 3 0.079 91.18 LR536843.1
    Streptococcus pneumoniae isolate 55896440-41bd-11e5-998e-3c4a9275d6c6 49.1 49.1 34 26% 3 0.079 91.18 LR216065.1
    Streptococcus pneumoniae isolate 569492b0-41bd-11e5-998e-3c4a9275d6c6 49.1 49.1 34 26% 3 0.079 91.18 LR216064.1
    Streptococcus pneumoniae strain 2245STDY6105839 49.1 49.1 34 26% 3 0.079 91.18 LR216063.1
    Streptococcus pneumoniae isolate GPS_HK_150-sc-2296816 49.1 49.1 34 26% 3 0.079 91.18 LR216062.1
    Streptococcus pneumoniae strain 2245STDY6178826 49.1 49.1 34 26% 3 0.079 91.18 LR216061.1
    Streptococcus pneumoniae strain 2245STDY6178787 49.1 49.1 34 26% 3 0.079 91.18 LR216060.1
    Streptococcus pneumoniae strain 2245STDY6106384 49.1 49.1 34 26% 3 0.079 91.18 LR216057.1
    Streptococcus pneumoniae strain 2245STDY6092949 49.1 49.1 34 26% 3 0.079 91.18 LR216055.1
    Streptococcus pneumoniae strain 2245STDY6106372 49.1 49.1 34 26% 3 0.079 91.18 LR216054.1
    Streptococcus pneumoniae strain 2245STDY6106337 49.1 49.1 34 26% 3 0.079 91.18 LR216051.1
    Streptococcus pneumoniae strain 2245STDY6092834 49.1 49.1 34 26% 3 0.079 91.18 LR216048.1
    Streptococcus pneumoniae strain 2245STDY6031034 49.1 49.1 34 26% 3 0.079 91.18 LR216047.1
    Streptococcus pneumoniae strain 2245STDY6092613 49.1 49.1 34 26% 3 0.079 91.18 LR216046.1
    Streptococcus pneumoniae strain 2245STDY6020221 49.1 49.1 34 26% 3 0.079 91.18 LR216045.1
    Streptococcus pneumoniae strain 2245STDY6020210 49.1 49.1 34 26% 3 0.079 91.18 LR216043.1
    Streptococcus pneumoniae strain 2245STDY6092581 49.1 49.1 34 26% 3 0.079 91.18 LR216042.1
    Streptococcus pneumoniae strain 2245STDY6031048 49.1 49.1 34 26% 3 0.079 91.18 LR216041.1
    Streptococcus pneumoniae strain 2245STDY6030848 49.1 49.1 34 26% 3 0.079 91.18 LR216040.1
    Streptococcus pneumoniae strain 2245STDY5775610 49.1 49.1 34 26% 3 0.079 91.18 LR216039.1
    Streptococcus pneumoniae strain 2245STDY5775666 49.1 49.1 34 26% 3 0.079 91.18 LR216037.1
    Streptococcus pneumoniae strain 2245STDY5775603 49.1 49.1 34 26% 3 0.079 91.18 LR216036.1
    Streptococcus pneumoniae isolate SA_GPS_SP505-sc-1895675 49.1 49.1 34 26% 3 0.079 91.18 LR216035.1
    Streptococcus pneumoniae strain 2245STDY5983173 49.1 49.1 34 26% 3 0.079 91.18 LR216034.1
    Streptococcus pneumoniae strain 2245STDY5868782 49.1 49.1 34 26% 3 0.079 91.18 LR216033.1
    Streptococcus pneumoniae strain 2245STDY5775874 49.1 49.1 34 26% 3 0.079 91.18 LR216032.1
    Streptococcus pneumoniae strain 2245STDY5982722 49.1 49.1 34 26% 3 0.079 91.18 LR216031.1
    Streptococcus pneumoniae strain 2245STDY5775545 49.1 49.1 34 26% 3 0.079 91.18 LR216030.1
    Streptococcus pneumoniae strain 2245STDY6093044 49.1 49.1 34 26% 3 0.079 91.18 LR216049.1
    Streptococcus pneumoniae strain 2245STDY5562412 49.1 49.1 34 26% 3 0.079 91.18 LR216028.1
    Streptococcus pneumoniae strain 2245STDY5775520 49.1 49.1 34 26% 3 0.079 91.18 LR216027.1
    Streptococcus pneumoniae strain 2245STDY5775485 49.1 49.1 34 26% 3 0.079 91.18 LR216026.1
    Streptococcus pneumoniae strain 2245STDY5562562 49.1 49.1 34 26% 3 0.079 91.18 LR216025.1
    Streptococcus pneumoniae strain 2245STDY5699394 49.1 49.1 34 26% 3 0.079 91.18 LR216024.1
    Streptococcus pneumoniae strain 2245STDY5699131 49.1 49.1 34 26% 3 0.079 91.18 LR216022.1
    Streptococcus pneumoniae strain 2245STDY5562600 49.1 49.1 34 26% 3 0.079 91.18 LR216021.1
    Streptococcus pneumoniae strain 2245STDY5562351 49.1 49.1 34 26% 3 0.079 91.18 LR216020.1
    Streptococcus pneumoniae strain 2245STDY5609237 49.1 49.1 34 26% 3 0.079 91.18 LR216019.1
    Streptococcus pneumoniae strain 2245STDY5605682 49.1 49.1 34 26% 3 0.079 91.18 LR216018.1
    Streptococcus pneumoniae strain 2245STDY5605669 49.1 49.1 34 26% 3 0.079 91.18 LR216017.1
    Streptococcus pneumoniae strain 2245STDY5605535 49.1 49.1 34 26% 3 0.079 91.18 LR216016.1

    DATA AVAILABILITY STATEMENT

    All data generated or analyzed during this study are included in this published article except the data in Appendix B (The KEGG analysis of biological pathways of the other 17 sRNAs) and Appendix C (More details about the BLASTN of 103 strains for seeking seed sequence), which are available in the figshare repository at https://doi.org/10.6084/m9.figshare.12310133.

      The full text of this article hosted at iucr.org is unavailable due to technical difficulties.